IN-DATE
035-XC-200-0: CSI ViperCath XC Peripheral Exchange Catheter, 5F x 200cm, Straight
Sign in to add this product to your favorites!
| Price: | $99.00 $9.90 per box of 1 |
|---|---|
| Quantity: | |
| In Stock: | 30 box of 1 |
| Status: | expired |
Related Items
QUICK VIEW
| 035-XC-200-1 $99.00 $9.90 per box of 1 CSI ViperCath XC Peripheral Exchange Catheter, 5F x 200cm, 30° Angled Expired Units in stock: 42 box of 1 | Order Qty |
QUICK VIEW
| 220-13-1000U $199.00 per box of 1 OrbusNeich Teleport Microcatheter 2.0F x 135cm Expired Units in stock: 12 box of 1 | Order Qty |
|
QUICK VIEW
| 220-15-1000U $199.00 per box of 1 OrbusNeich Teleport Microcatheter 2.0F x 150cm Expired Units in stock: 3 box of 1 | Order Qty |
|
QUICK VIEW
| 221-13-1000U $199.00 $139.30 per box of 1 OrbusNeich Teleport Control Microcatheter 2.1F x 135cm Expired Units in stock: 31 box of 1 | Order Qty |
|
QUICK VIEW
| 221-15-1000U $199.00 per box of 1 OrbusNeich Teleport Control Microcatheter 2.1F x 150cm Expired Units in stock: 12 box of 1 | Order Qty |
Additional Details
Abbott CSI Cardiovascular Systems, Inc ViperCath XC
The longest length exchange catheter available to guide and support guide wire access in the vasculature and allow for wire exchanges while providing a conduit for delivering saline and contrast. Designed for kink resistance, torqueability and support during delivery.
AccessGUDID Info
- FDA Product Code: DQY
- FDA Product Code Name: Catheter, Percutaneous
- GMDN Term Code: 17846
- GMDN Term Name: Vascular guide-catheter, single-use
- GMDN Term Description: A flexible tube intended to be used for the percutaneous transluminal passage and placement of a diagnostic/interventional catheter, lead (e.g., pacing lead, balloon dilatation catheter), needle or guidewire through its lumen(s), within the vascular system. It may be rigid or flexible, non-steerable or steerable, single or multiple lumen(s), and the distal section can have a variety of preformed shapes (e.g., straight, hockey stick). It is not intended solely for infusion, is not intended to access superselective small vessels, and does not include a transseptal needle. It may include a disposable percutaneous introduction set or shaft visualization electrodes. This is a single-use device.
Manufacturer
Cardiovascular Systems, Inc. (CSI), now a part of Abbott, specialized in innovative solutions for the treatment of peripheral and coronary artery disease through its proprietary orbital atherectomy systems. CSI’s flagship technologies include the Diamondback 360® Peripheral Orbital Atherectomy System and the Diamondback 360® Coronary Orbital Atherectomy System, both designed to modify calcified plaque and improve vessel compliance prior to stent placement or balloon angioplasty.
These systems use a diamond-coated crown that orbits within the vessel, sanding away plaque while preserving healthy tissue and facilitating better device delivery. CSI’s focus on challenging arterial disease—particularly in heavily calcified lesions—made it a valuable addition to Abbott’s vascular portfolio following its acquisition in 2023, further expanding minimally invasive treatment options for complex cardiovascular cases.
